Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection [Phase 1]
This update describes a Phase 1 clinical trial investigating a neoantigen vaccine in patients with resectable esophageal cancer following ne…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. [Phase 1]
Phase 1 trial update of Naptumomab Estafenatox in combination with durvalumab in selected advanced or metastatic solid tumors, including eso…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Clinical trial update reports the completion of a Phase 1/2 safety and efficacy study of CTX131 in adults with relapsed or refractory solid …
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: AI-assisted Endoscopic Ultrasound Grading of Early Esophageal Cancer Invasion Depth: A Multicenter, Prospective, Randomized Cohort Study [NA]
A multicenter, prospective randomized cohort study is evaluating AI-assisted endoscopic ultrasound grading of invasion depth in early esopha…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer Using Durvalumab-680LT and Nivolumab-800CW [Phase 1]
A Phase 1 clinical trial update exploring optical imaging of PD-1/PD-L1 in locally advanced esophageal cancer using Durvalumab-680LT and Niv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors [Phase 2]
Phase 2 trial evaluating intestinal low-dose radiotherapy combined with immunotherapy for immune-resistant metastatic malignant solid tumors…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma. [Phase 1, Phase 2]
A phase 1/2 trial is evaluating camrelizumab in combination with radiotherapy as neoadjuvant therapy for esophageal cancer, and the study is…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer [Phase 2]
A Phase 2 clinical trial evaluating the combination of radiochemotherapy and immunotherapy for unresectable esophageal cancer has completed.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers [Phase 2]
Phase II clinical study evaluating SSGJ-706 in combination therapy for advanced gastrointestinal cancers is not yet recruiting. The study in…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 [Phase 1, Phase 2]
A phase 1/2 trial evaluating afuresertib in combination with sintilimab and chemotherapy in selected solid tumors resistant to prior PD-1/PD…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer
This clinical trial is evaluating endoluminal vacuum therapy to prevent anastomotic leakage after esophagectomy in patients with esophageal …
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]
The document reports an ongoing Phase 2 clinical trial evaluating LBL-007 in combination with tislelizumab and chemotherapy for unresectable…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Evaluations of Alcohol Warning Labels [NA]
Completed clinical trial evaluating the impact of alcohol warning labels on cancer-related outcomes, with findings related to oral cancer, e…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Relationship Between Endoscopic Ultrasound Staging and Degree of Stricture in Esophageal Cancer
This completed clinical trial update examines the relationship between endoscopic ultrasound staging and the degree of stricture in esophage…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: 18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer [Phase 1]
Phase 1 clinical trial investigating 18F-AraG PET/CT as a non-invasive imaging biomarker to assess chemoradiation response in esophageal can…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating liquid nitrogen spray cryotherapy before neoadjuvant systemic therapy for esophageal adenocarcinoma; the…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter [Phase 2]
A Phase 2 clinical trial investigating ALI after radiation therapy in patients with lung cancer and esophageal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors [Phase 2]
A Phase 2 trial evaluating niraparib in patients with advanced PALB2-mutated tumors was terminated; results have been posted for multiple so…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Clinical trial SYNERGY-AI is an AI-based precision oncology matching and registry study sponsored by Massive Bio, currently recruiting acros…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies [Phase 1]
Open-label Phase 1 safety and tolerability study of INCB062079 in patients with advanced hepatocellular carcinoma and other malignancies; st…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of the monoclonal antibody IMT-009 in various advanced solid tumors and lymphomas, with t…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer [NA]
This trial update describes the effects of zinc supplementation on quality of life in patients with gastrointestinal cancers. The study has …
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
This clinical trial update describes a study evaluating detection of tumor cells and tumor DNA in blood, urine, and bone marrow across multi…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial [Phase 3]
A Phase 3 randomized trial comparing patient-reported symptom care to usual care after esophageal cancer surgery is described. The study is …
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers [NA]
A UCSF-led clinical trial is evaluating radiation therapy for metastatic gastrointestinal cancers, and the study is currently recruiting.